Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005, 149(2):335-337 | DOI: 10.5507/bp.2005.053

GALANTAMINE ANTIACETYLCHOLINESTERASE ACTIVITY IN RAT BRAIN INFLUENCED BY L-CARNITINE

Zbyněk Svobodaa, Jaroslav Květinaa, Josef Herinka, Jiří Bajgarb, Lucie Bartoąováb, Vladimír Paličkac, Pavel ®ivnýc
a Institute of Experimental Biopharmaceutics, Joint Research Centre of the Czech Academy of Sciences and PRO.MED.CS Praha a.s., Hradec Králové, Czech Republic
b Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic
c Faculty of Medicine, Charles University, Hradec Králové, Czech Republic

Galantamine (GAL) is a selective, competitive and reversible acetylcholinesterase (AChE) inhibitor, which increases the activity of the cholinergic system and hence gives rise to an improvement of cognitive functions in patients suffering from dementia of Alzheimer type. L-Carnitine (CAR) is a natural component of the mammalian tissue and is known to increase penetration of some chemical compounds/groups across biological membranes. The aim of this study was to evaluate the influence of pretreatment with CAR on AChE inhibition caused by GAL in selected brain parts in rat (basal ganglia, septum, frontal cortex, hippocampus) and in hypophysis, which does not lay beyond the blood-brainbarrier. During the first stage of the study, GAL was administered i.m. in different doses ranging from 2.5 to 10 mg/kg. The highest degree of AChE dose dependent inhibition was observed in hypophysis, while that in CNS was lower and became apparent in frontal cortex and hippocampus only after the administration of the dose of 10 mg/kg i.m. In the second stage, CAR was administered daily during 3 consecutive days at a dose of 250 mg/kg p.o. prior to the administration of GAL (10 mg/kg i.m.). Pretreatment with CAR enhanced trend of AChE inhibition in all selected brain parts comparing with single GAL administration, however, significant difference was not observed. Comparing these results with control group, statistical significance was found in frontal cortex, hippocampus and hypophysis.

Keywords: Galantamine, Acetylcholinesterase, L-Carnitine, Brain, Rat, Alzheimer’s disease

Received: June 10, 2005; Accepted: September 25, 2005; Published: December 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svoboda, Z., Květina, J., Herink, J., Bajgar, J., Bartoąová, L., Palička, V., & ®ivný, P. (2005). GALANTAMINE ANTIACETYLCHOLINESTERASE ACTIVITY IN RAT BRAIN INFLUENCED BY L-CARNITINE. Biomedical papers149(2), 335-337. doi: 10.5507/bp.2005.053
Download citation

References

  1. Farlow MR. (2003) Clinical pharmacokinetics of galantamine. Clin Pharmacokinet 42, 1383-92. Go to original source... Go to PubMed...
  2. Evans AM, Fornasini G. (2003) Pharmacokinetics of L-carnitine. Clin Pharmacokinet 42, 941-67. Go to original source... Go to PubMed...
  3. Svoboda Z, Herink J, Bajgar J, Květina J. (2001) The influence of L-carnitine on biodistribution and effect of 7-methoxytacrine in rat. Homeostasis 41, 49-51.
  4. König JFR, Klippel RA. The rat brain. Baltimore: Williams and Wilkins Co., 1963.
  5. Ellman GL, Courtney DK, Andres V, Featherstone RM. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7, 88-95. Go to original source... Go to PubMed...
  6. Bajgar J, Herink J, Fusek J. (2001) Changes of individual molecular forms of the rat brain acetylcholinesterase following administration of nerve agents. Homeostasis 41, 233-6.